Profiling the proteome in renal transplantation

Proteomics - Clinical Applications

Volumn 5, Issue 5-6, 2011, Pages 269-280

  Sigdel, Tara K ^a   Lee, Sangho ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; Biomarker discovery; Organ transplantation; Urine

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; MICRORNA; PROTEOME;

FRACTIONATION; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; HUMAN; IMMUNE RESPONSE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PEPTIDOMICS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; HUMANS; KIDNEY TRANSPLANTATION; PROTEOMICS;

EID: 79957624610     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000117     Document Type: Review

References (90)

1. Gulanikar, A. C., MacDonald, A. S., Sungurtekin, U., Belitsky, P., The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992, 53, 323-328.
2. Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E. et al., Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 2000, 342, 605-612.
3. Li, B., Hartono, C., Ding, R., Sharma, V. K. et al., Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 2001, 344, 947-954.
4. Vidhun, J., Masciandro, J., Varich, L., Salvatierra, O., Jr., Sarwal, M., Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients. Transplantation 2003, 76, 552-557.
5. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C. et al., Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921.
6. Sigdel, T. K., Lau, K., Schilling, J., Sarwal, M. M., Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin. Transplant. 2008, 22, 617-623.
7. Sigdel, T. K., Klassen, R. B., Sarwal, M. M., Interpreting the proteome and peptidome in transplantation. Adv. Clin. Chem. 2009, 47, 139-169.
8. Sigdel, T. K., Lau, K., Schilling, J., Sarwal, M., Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin. Transplant. 2008, 22, 617-623.
9. Hricik, D. E., Rodriguez, V., Riley, J., Bryan, K. et al., Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am. J. Transplant. 2003, 3, 878-884.
10. Kowalski, R. J., Post, D. R., Mannon, R. B., Sebastian, A. et al., Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006, 82, 663-668.
11. Vasconcellos, L. M., Schachter, A. D., Zheng, X. X., Vasconcellos, L. H. et al., Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998, 66, 562-566.
12. Simon, T., Opelz, G., Wiesel, M., Ott, R. C., Susal, C., Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am. J. Transplant. 2003, 3, 1121-1127.
13. Yannaraki, M., Rebibou, J. M., Ducloux, D., Saas, P. et al., Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl. Int. 2006, 19, 759-768.
14. Renesto, P. G., Ponciano, V. C., Cenedeze, M. A., Saraiva Camara, N. O., Pacheco-Silva, A., High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am. J. Transplant. 2007, 7, 1661-1665.
15. Schaub, S., Nickerson, P., Rush, D., Mayr, M. et al., Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am. J. Transplant. 2009, 9, 1347-1353.
16. Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O. et al., Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 2005, 5, 729-738.
17. Camara, N. O., Silva, M. S., Nishida, S., Pereira, A. B., Pacheco-Silva, A., Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival. Transplantation 2004, 78, 269-275.
18. Teppo, A. M., Honkanen, E., Finne, P., Tornroth, T., Gronhagen-Riska, C., Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome. Transplantation 2004, 78, 719-724.
19. Hollmen, M. E., Kyllonen, L. E., Inkinen, K. A., Lalla, M. L., Salmela, K. T., Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int. 2011, 79, 89-98.
20. Sigdel, T., Kaushal, A., Gritsenko, M., Norbeck, A. et al., Novel shotgun proteomics approach identifies proteins specific for acute renal transplant rejection. Am. J. Transplant. 2010, 10, 289-290.
21. Ling, X. B., Sigdel, T. K., Lau, K., Ying, L. et al., Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J. Am. Soc. Nephrol. 2010, 21, 646-653.
22. Chen, R., Sigdel, T. K., Li, L., Kambham, N. et al., Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput. Biol. 2010, 6, e100940.
23. Ansari, M. J., Sayegh, M. H., Clinical transplantation tolerance: the promise and challenges. Kidney Int. 2004, 65, 1560-1563.
24. Aebersold, R., A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom. 2003, 14, 685-695.
25. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
26. Zhu, W., Smith, J. W., Huang, C. M., Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010, 2010, 840518.
27. Nagaraj, N., Mann, M., Quantitative analysis of the intra and inter individual variability of the normal urinary proteome. J. Proteome Res. 2011, 10, 637-645.
28. Sigdel, T., Ling, B., Lau, K., Ying, L. H. et al., Integrative urinary peptidomics in renal transplantation identifies novel biomarkers for acute rejection. Am. J. Transplant. 2010, 10, 60-66.
29. Quintana, L. F., Campistol, J. M., Alcolea, M. P., Banon-Maneus, E. et al., Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol. Cell. Proteomics 2009, 8, 1658-1673.
30. Sigdel, T. K., Ling, X. B., Lau, K., Li, L. et al., Urinary peptidomic analysis identifies potential biomarkers for acute rejection of renal. Clin. Proteomics 2009, 5, 103-113.
31. Metzger, J., Kirsch, T., Schiffer, E., Ulger, P. et al., Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int. 2010, 78, 1252-1262.
32. Coon, J. J., Zurbig, P., Dakna, M., Dominiczak, A. F. et al., CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin. Appl. 2008, 2, 964-973.
33. Norden, A. G., Rodriguez-Cutillas, P., Unwin, R. J., Clinical urinary peptidomics: learning to walk before we can run. Clin. Chem. 2007, 53, 375-376.
34. Reichelt, O., Muller, J., von Eggeling, F., Driesch, D. et al., Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology 2006, 67, 472-475.
35. Schaub, S., Rush, D., Wilkins, J., Gibson, I. W. et al., Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 219-227.
36. Jahnukainen, T., Malehorn, D., Sun, M., Lyons-Weiler, J. et al., Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J. Am. Soc. Nephrol. 2006, 17, 3248-3256.
37. Lilley, K. S., Friedman, D. B., All about DIGE: quantification technology for differential-display 2D-gel proteomics. Exp. Rev. Proteomics 2004, 1, 401-409.
38. Rozanas, C. R., Loyland, S. M., Capabilities using 2-D DIGE in proteomics research: the new gold standard for 2-D gel electrophoresis. Methods Mol. Biol. 2008, 441, 1-18.
39. Unlu, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
40. Banon-Maneus, E., Diekmann, F., Carrascal, M., Quintana, L. F. et al., Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers. Transplantation 2010, 89, 548-558.
41. Li, L., Wadia, P., Chen, R., Kambham, N. et al., Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc. Natl. Acad. Sci. USA 2009, 106, 4148-4153.
42. Mattoon, D., Michaud, G., Merkel, J., Schweitzer, B., Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling. Exp. Rev. Proteomics 2005, 2, 879-889.
43. Sutherland, S. M., Li, L., Sigdel, T. K., Wadia, P. P. et al., Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int. 2009, 76, 1277-1283.
44. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
45. Gonzalez-Buitrago, J. M., Ferreira, L., Lorenzo, I., Urinary proteomics. Clin. Chim. Acta 2007, 375, 49-56.
46. Candiano, G., Musante, L., Bruschi, M., Petretto, A. et al., Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 17, 3139-3148.
47. Magistroni, R., Ligabue, G., Lupo, V., Furci, L. et al., Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrol. Dial. Transplant. 2009, 24, 1672-1681.
48. Musante, L., Candiano, G., Petretto, A., Bruschi, M. et al., Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 2007, 18, 799-810.
49. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
50. Thongboonkerd, V., Practical points in urinary proteomics. J. Proteome Res. 2007, 6, 3881-3890.
51. Knuiman, J. T., Hautvast, J. G., van der Heyden, L., Geboers, J. et al., A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum. Nutr. Clin. Nutr. 1986, 40, 229-237.
52. Harris, S. A., Purdham, J. T., Corey, P. N., Sass-Kortsak, A. M., An evaluation of 24-hour urinary creatinine excretion for use in identification of incomplete urine collections and adjustment of absorbed dose of pesticides. Am. Ind. Hyg. Assoc. J. 2000, 61, 649-657.
53. Garde, A. H., Hansen, A. M., Kristiansen, J., Knudsen, L. E., Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration. Ann. Occup. Hyg. 2004, 48, 171-179.
54. Thongboonkerd, V., Chutipongtanate, S., Kanlaya, R., Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J. Proteome Res. 2006, 5, 183-191.
55. Khan, A., Packer, N. H., Simple urinary sample preparation for proteomic analysis. J. Proteome Res. 2006, 5, 2824-2838.
56. Mischak, H., Kolch, W., Aivaliotis, M., Bouyssie, D. et al., Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin. Appl. 2010, 4, 464-478.
57. Echan, L. A., Tang, H. Y., Ali-Khan, N., Lee, K., Speicher, D. W., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
58. Fountoulakis, M., Juranville, J. F., Jiang, L., Avila, D. et al., Depletion of the high-abundance plasma proteins. Amino Acids 2004, 27, 249-259.
59. Wang, L., Li, F., Sun, W., Wu, S. et al., Concanavalin A-captured glycoproteins in healthy human urine. Mol. Cell. Proteomics 2006, 5, 560-562.
60. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
61. Sun, W., Li, F., Wu, S., Wang, X. et al., Human urine proteome analysis by three separation approaches. Proteomics 2005, 5, 4994-5001.
62. Pieper, R., Gatlin, C. L., McGrath, A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
63. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 2006, 7, R80.
64. Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D. et al., Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 2008, 20, 363-379.
65. Sigdel, T. K., Kaushal, A., Gritsenko, M., Norbeck, A. D. et al., Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin. Appl. 2010, 4, 32-47.
66. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
67. Mirgorodskaya, O. A., Kozmin, Y. P., Titov, M. I., Korner, R. et al., Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom. 2000, 14, 1226-1232.
68. Nakorchevsky, A., Hewel, J. A., Kurian, S. M., Mondala, T. S. et al., Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J. Am. Soc. Nephrol. 2010, 21, 362-373.
69. Sigdel, T. K., Sarwal, M. M., The proteogenomic path towards biomarker discovery. Pediatr. Transplant. 2008, 12, 737-747.
70. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotech. 2006, 24, 971-983.
71. Kirk, A. D., Location, location, location: regional immune mechanisms critically influence rejection. Nat. Med. 2002, 8, 553-555.
72. Ginsburg, G. S., McCarthy, J. J., Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001, 19, 491-496.
73. Goldfarb-Rumyantzev, A. S., Personalized medicine and prediction of outcome in kidney transplant. Am. J. Kidney Dis. 2010, 56, 817-819.
74. Lampreabe, I., Gainza de los Rios, F. J., Arrieta Gutierrez, A., Jofre-Monseny, L. et al., Toward personalized medicine in renal transplantation. Transplant. Proc. 2010, 42, 2864-2867.
75. Coto, E., Tavira, B., Pharmacogenetics of calcineurin inhibitors in renal transplantation. Transplantation 2009, 88, S62-S67.
76. Wavamunno, M. D., Chapman, J. R., Individualization of immunosuppression: concepts and rationale. Curr. Opin. Organ Transplant. 2008, 13, 604-608.
77. Hesselink, D. A., van Gelder, T., van Schaik, R. H., The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression? Pharmacogenomics 2005, 6, 323-337.
78. Holt, K. E., Parkhill, J., Mazzoni, C. J., Roumagnac, P. et al., High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat. Genet. 2008, 40, 987-993.
79. Wang, Z., Gerstein, M., Snyder, M., RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57-63.
80. Gao, Y., Wu, K., Xu, Y., Zhou, H. et al., Characterization of acute renal allograft rejection by human serum proteomic analysis. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2009, 29, 585-591.
81. Clarke, W., Silverman, B. C., Zhang, Z., Chan, D. W. et al., Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 2003, 237, 660-664; discussion 664-665.
82. O'Riordan, E., Orlova, T. N., Mei, J. J., Butt, K. et al., Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 3240-3248.
83. O'Riordan, E., Orlova, T. N., Podust, V. N., Chander, P. N. et al., Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am. J. Transplant. 2007, 7, 930-940.
84. Kurian, S. M., Heilman, R., Mondala, T. S., Nakorchevsky, A. et al., Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 2009, 4, e6212.
85. Freue, G. V., Sasaki, M., Meredith, A., Gunther, O. P. et al., Proteomic signatures in plasma during early acute renal allograft rejection. Mol. Cell. Proteomics 2010, 9, 1954-1967.
86. Wu, D., Zhu, D., Xu, M., Rong, R. et al., Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection. J. Proteome Res. 2010, 10, 175-181.
87. Wittke, S., Haubitz, M., Walden, M., Rohde, F. et al., Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am. J. Transplant. 2005, 5, 2479-2488.
88. Perez, V., Navarro-Munoz, M., Bayes, B., Lauzurica, R. et al., Effect of low doses of atorvastatin on the urinary peptide profile of kidney transplant patients. Transplant. Proc. 2009, 41, 2111-2114.
89. Sui, W., Huang, L., Dai, Y., Chen, J. et al., Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS. Clin. Exp. Med. 2010, 10, 259-268.
90. Li, L., Chen, A., Chaudhuri, A., Kambham, N. et al., Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010, 89, 312-319.